Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-002324
Filing Date
2022-03-18
Accepted
2022-03-18 16:36:51
Documents
1
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 10234
  Complete submission text file 0001179110-22-002324.txt   11718
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Tessari Eben (Reporting) CIK: 0001867899 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 22753027